RNF43

RNF43

RNF43 분자 정보

Molecule Name
E3 ubiquitin-protein ligase RNF43
Drug Development Progress
임상 약물 수1
시판 약물 수0
최고 연구 개발 단계Phase 1 Clinical
표적 별명
분자 배경
E3 ubiquitin-protein ligase that acts as a negative regulator of the Wnt signaling pathway by mediating the ubiquitination, endocytosis and subsequent degradation of Wnt receptor complex components Frizzled. Acts on both canonical and non-canonical Wnt signaling pathway. Along with RSPO2 and ZNRF3, constitutes a master switch that governs limb specification (By similarity)

RNF43 제품 목록

No Data
You Have Viewed 0 Of 0 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

임상 약물 정보

영어 이름연구 코드연구 개발 단계회사적응증임상 시험
SZN-043SZN-043; SWEETS-1Phase 1 ClinicalSurrozen Inc
Hepatitis, Alcoholic; Liver Cirrhosis
상세